Big-Pharma (Healthcare)

What Should Independent Research Providers be Doing to Increase Market Share?

The Science of Selling Financial Research
September 18 2019
In our previous post, we noted that there is a $9.3B market for financial research but that independent research firms tend to be misguided in their approach to gaining market share.  So, what should IRPs do to increase market share?  We see three main areas to focus on: 1. Strengthen the “three pillars of business”. […]
READ »

Is Independent Research Dead?

The Science of Selling Financial Research
September 13 2019
As the owner of a business that makes its living selling independent research, there are many times that I wake up in the middle of the night in a cold sweat. It only takes one or two cancellations from buy-side clients to get my mind racing:  “The research market is shrinking.  MiFID II means the […]
READ »

What the Buy-Side Wants…

The Science of Selling Financial Research
September 12 2019
At the Research Alliance, we are proud that our institutional buy-side client base considers us their ‘Trusted Advisors’ when it comes to sourcing independent research, and for sourcing alpha-generating non-consensus investment ideas for their portfolios. In the past 14 years we have surveyed and met with over 1,500 buy-side investment firms, and closed research deals […]
READ »